📊 BHST Key Takeaways
Investment Thesis
BioHarvest Sciences presents substantial analytical risk due to complete absence of reportable financial data across all fundamental metrics. With zero revenue, no profitability indicators, no balance sheet data, and only 1 metric available from SEC filings, the company appears to be pre-revenue or non-operational. The lack of insider activity (0 Form 4 filings in 90 days) combined with missing financial data suggests minimal operational progress.
BHST Strengths
- Listed on Nasdaq indicating regulatory compliance standards
- CIK registration demonstrates SEC reporting entity status
- Operating in pharmaceutical sector with potential long-term market opportunity
BHST Risks
- Complete absence of revenue and profitability metrics
- No balance sheet data available indicating non-reporting status or financial distress
- Zero insider transactions in 90 days suggests lack of management confidence
- Pharmaceutical sector carries high R&D costs and regulatory risk
- Insufficient financial transparency for fundamental analysis
Key Metrics to Watch
- Revenue generation and gross margin initiation
- Balance sheet composition and cash runway
- Insider buying activity and management confidence indicators
- SEC filing frequency and data availability improvements
- Cash burn rate and path to profitability
BHST Financial Metrics
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
BHST Profitability Ratios
BHST vs Healthcare Sector
How BIOHARVEST SCIENCES INC. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
BHST Balance Sheet & Liquidity
BHST Growth Metrics (YoY)
BHST SEC Filings
Access official SEC EDGAR filings for BIOHARVEST SCIENCES INC. (CIK: 0001723464)
❓ Frequently Asked Questions about BHST
What is the AI rating for BHST?
BIOHARVEST SCIENCES INC. (BHST) has an AI rating of SELL with 95% confidence, based on fundamental analysis of SEC EDGAR filings.
What are BHST's key strengths?
Listed on Nasdaq indicating regulatory compliance standards. CIK registration demonstrates SEC reporting entity status.
What are the risks of investing in BHST?
Complete absence of revenue and profitability metrics. No balance sheet data available indicating non-reporting status or financial distress.
What is BHST's revenue and growth?
BIOHARVEST SCIENCES INC. reported revenue of N/A.
Does BHST pay dividends?
BIOHARVEST SCIENCES INC. does not currently pay dividends.
Where can I find BHST SEC filings?
Official SEC filings for BIOHARVEST SCIENCES INC. (CIK: 0001723464) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is BHST's EPS?
BIOHARVEST SCIENCES INC. has a diluted EPS of $0.00.
How is the AI analysis conducted?
Our AI (Claude) analyzes publicly available SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports to evaluate financial health, profitability ratios, balance sheet strength, and growth metrics.